Suven Pharmaceuticals Ltd
NSE:SUVENPHAR
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is SUVENPHAR's stock price target?
Not Available
SUVENPHAR doesn't have any price targets made by Wall Street professionals.
What is Suven Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
46%
For the last 4 years the
compound annual growth rate for
Suven Pharmaceuticals Ltd's revenue is
6%.
The projected
CAGR
for the next 4 years is
46%.
What is Suven Pharmaceuticals Ltd's Operating Income forecast?
Projected CAGR
44%
For the last 4 years the
compound annual growth rate for
Suven Pharmaceuticals Ltd's operating income is
0%.
The projected
CAGR
for the next 4 years is
44%.
What is Suven Pharmaceuticals Ltd's Net Income forecast?
Projected CAGR
40%
For the last 4 years the
compound annual growth rate for
Suven Pharmaceuticals Ltd's net income is
-1%.
The projected
CAGR
for the next 4 years is
40%.
